East Rockaway, NY, United States of America

Marek Biestek


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • East Rockaway, NY (US) (2014 - 2017)
  • San Diego, CA (US) (2018 - 2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marek Biestek

Introduction

Marek Biestek is a notable inventor based in East Rockaway, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders. With a total of five patents to his name, Biestek's work is recognized for its potential impact on medical science.

Latest Patents

Marek Biestek's latest patents focus on pantothenate derivatives for the treatment of neurological disorders. These patents describe compounds that can be used in pharmaceutical compositions aimed at treating conditions such as pantothenate kinase-associated neurodegeneration. The compounds are defined by specific formulas and include methods for their application in medical treatments.

Career Highlights

Biestek is currently associated with Retrophin, Inc., a company dedicated to developing innovative therapies for serious diseases. His work at Retrophin has allowed him to explore and develop new treatments that could significantly improve patient outcomes in neurology.

Collaborations

Marek Biestek has collaborated with notable colleagues in his field, including Andrew Vaino and Martin Shkreli. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Marek Biestek's contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders, highlight his innovative spirit and dedication to improving healthcare. His work continues to pave the way for new therapeutic options in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…